Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Avindra Nath MD

Avindra Nath MD

Clinical Director, National Institute of Neurological Disorders and Stroke (NINDS); Chief, Section of Infections of the Nervous System, National Institutes of Health, Bethesda, Maryland

Dr. Avindra Nath is a physician–scientist who specializes in the field of neuro-immunology and neurovirology. His research is focused on the clinical manifestations, pathophysiology and treatment of emerging neurological infections with a focus on HIV infection. In recent years, he has studied the neurological complications of endogenous retroviruses, Ebola, Zika virus, and SARS-CoV-2, and he conducts research on patients with undiagnosed neuroinflammatory disorders. He is internationally recognized for his contributions and has served on advisory committees to the NIH, CDC, FDA, and WHO.

Dr. Nath is the Clinical Director of the National Institute of Neurological Disorders and Stroke (NINDS) at NIH, where he is also Chief of the Section of Infections of the Nervous System, Director of the Translational Center for Neurological Sciences, and Director of the Neuroimmunology and Neurovirology Fellowship Program.

Disclosures

  • Advisory boards: National Institutes of Health; Centers for Disease Control; Food and Drug Administration; World Health Organization

Recent Contributions to PracticeUpdate:

  1. Neurobiology of COVID-19
  2. Dysregulation of Brain and Choroid Plexus Cell Types in Severe COVID-19
  3. IL-8: Biomarker to Differentiate Guillain-Barré Syndrome From CIDP
  4. COVID-19 Encephalopathies Present NVU Alterations Without Evidence for Strong Neuroinflammation
  5. Current Concepts in Cognitive Impairment in Multiple Sclerosis
  6. An Overview of Recent Comparative Trials of Multiple Sclerosis Therapies
  7. Neurological Complications Associated With COVID-19: Part 1
  8. Neurological Complications Associated With COVID-19: Part 2
  9. 2020 Top Stories in Neurology: Multiple Sclerosis
  10. The Impact of Gender on Career Success in Neurology

Most Read This Week

Recently Updated